STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICE
  4. [Form 4] Intercontinental Exchange, Inc. Insider Trading Activity

[Form 4] Intercontinental Exchange, Inc. Insider Trading Activity

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Intercontinental Exchange General Counsel Andrew J. Surdykowski reported an exercise-and-sell transaction in company stock. On May 26, 2026, he exercised employee stock options to acquire 2,065 shares of common stock at $57.31 per share, then sold a total of 4,573 shares in open-market transactions around $151 per share pursuant to a pre-established Rule 10b5-1 trading plan. After these transactions, he directly holds 45,473 shares of common stock, alongside remaining fully vested options and equity awards including restricted stock units and performance-based units that vest over multi-year periods.

Positive

  • None.

Negative

  • None.
Insider Surdykowski Andrew J
Role General Counsel
Sold 4,573 shs ($693K)
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) Holding 2,065 $0.00 --
Exercise Common Stock 2,065 $57.31 $118K
Sale Common Stock 1,965 $150.9729 $297K
Sale Common Stock 2,608 $151.9981 $396K
Holdings After Transaction: Employee Stock Option (right to buy) Holding — 4,129 shares (Direct, null); Common Stock — 50,046 shares (Direct, null)
Footnotes (1)
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025. The price range for the aggregate amount sold by the direct holder is $150.46 - $151.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The price range for the aggregate amount sold by the direct holder is $151.95 - $152.00. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The common stock number referred in Table I is an aggregate number and represents 38,299 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. These options are fully vested.
Shares sold 4,573 shares Common stock sold in open-market transactions on May 26, 2026
Sale prices $151.9981 and $150.9729 per share Average prices for 2,608 and 1,965 ICE shares sold
Options exercised 2,065 shares at $57.31/share Employee stock option exercise into ICE common stock
Shares held after 45,473 shares Direct ICE common stock holdings following transactions
Options remaining 4,129 options Employee stock options outstanding after exercise, expiring January 18, 2027
Equity award components 38,299 shares, 5,734 RSUs, 1,440 PSUs Breakdown of aggregate common stock number in Table I
Trading plan effective date November 25, 2025 Rule 10b5-1 plan governing reported stock sales
Option expiration January 18, 2027 Expiration date for the option grant exercised and remaining
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units ("RSUs") financial
"represents 38,299 shares of common stock and 5,734 unvested restricted stock units ("RSUs")..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
performance based restricted stock units ("PSUs") financial
"and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied."
TSR PSUs financial
"The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares..."
EBITDA PSUs financial
"The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs..."
Deal Incentive Awards financial
"performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares..."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Surdykowski Andrew J
(Last)(First)(Middle)
5660 NEW NORTHSIDE DRIVE
(Street)
ATLANTA GEORGIA 30328
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Intercontinental Exchange, Inc. [ ICE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/26/2026M2,065(1)A$57.3150,046D
Common Stock05/26/2026S1,965(1)D$150.9729(2)48,081D
Common Stock05/26/2026S2,608(1)D$151.9981(3)45,473(4)(5)(6)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy) Holding$57.3105/26/2026M2,065 (7)01/18/2027Common Stock2,065$04,129D
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
2. The price range for the aggregate amount sold by the direct holder is $150.46 - $151.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
3. The price range for the aggregate amount sold by the direct holder is $151.95 - $152.00. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
4. The common stock number referred in Table I is an aggregate number and represents 38,299 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
5. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
6. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
7. These options are fully vested.
/s/ Octavia N. Spencer, Attorney-in-fact05/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did ICE General Counsel Andrew Surdykowski report?

He reported an option exercise and related stock sales. On May 26, 2026, he exercised options for 2,065 ICE shares at $57.31 and sold 4,573 common shares in open-market trades executed under a Rule 10b5-1 trading plan.

How many Intercontinental Exchange (ICE) shares did the General Counsel sell and at what prices?

He sold 4,573 ICE common shares in total. One sale covered 2,608 shares at an average price of $151.9981, and another covered 1,965 shares at an average price of $150.9729, both executed in open-market transactions.

What options did ICE’s General Counsel exercise in this Form 4 filing?

He exercised employee stock options for 2,065 shares. The options had a conversion or exercise price of $57.31 per share, related to common stock, and are described as fully vested, with an option grant expiring on January 18, 2027.

How many ICE shares does the General Counsel hold after these transactions?

He directly holds 45,473 shares of ICE common stock after the trades. A footnote explains this aggregate common stock figure also reflects a mix of shares plus unvested restricted stock units and performance-based restricted stock units tracked in the same total.

Was the ICE General Counsel’s stock sale pre-planned under a Rule 10b5-1 plan?

Yes, the sales were executed under a Rule 10b5-1 trading plan. A footnote states the plan was approved and became effective as of November 25, 2025, indicating the transactions were pre-arranged rather than opportunistic discretionary trades.

What long-term equity awards does the ICE General Counsel have outstanding?

He holds RSUs and several types of PSUs with future vesting dates. Footnotes describe TSR PSUs and EBITDA PSUs with outcomes determined in February 2027–2029, and Deal Incentive Award PSUs with performance measurement through December 2026–2028 plus further time-based vesting and holding requirements.